Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 8 studies | 20% ± 4% | |
plasma cell | 8 studies | 26% ± 11% | |
epithelial cell | 5 studies | 34% ± 9% | |
CD8-positive, alpha-beta T cell | 5 studies | 17% ± 1% | |
plasmablast | 4 studies | 42% ± 17% | |
basal cell | 4 studies | 28% ± 8% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 21% ± 4% | |
goblet cell | 4 studies | 19% ± 2% | |
non-classical monocyte | 3 studies | 26% ± 6% | |
endothelial cell | 3 studies | 26% ± 6% | |
ciliated cell | 3 studies | 28% ± 2% | |
innate lymphoid cell | 3 studies | 25% ± 3% | |
group 3 innate lymphoid cell | 3 studies | 29% ± 9% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 44% ± 15% | |
erythroblast | 3 studies | 48% ± 22% | |
hematopoietic stem cell | 3 studies | 17% ± 1% | |
CD4-positive, alpha-beta memory T cell | 3 studies | 16% ± 1% | |
regulatory T cell | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1218.74 | 459 / 459 | 100% | 53.05 | 1118 / 1118 |
esophagus | 100% | 1595.65 | 1445 / 1445 | 100% | 52.82 | 183 / 183 |
stomach | 100% | 1384.66 | 359 / 359 | 100% | 54.88 | 286 / 286 |
intestine | 100% | 1779.14 | 966 / 966 | 100% | 57.05 | 526 / 527 |
bladder | 100% | 1143.76 | 21 / 21 | 100% | 56.23 | 503 / 504 |
brain | 100% | 1139.23 | 2635 / 2642 | 100% | 48.30 | 705 / 705 |
lung | 100% | 1393.08 | 576 / 578 | 100% | 51.12 | 1155 / 1155 |
prostate | 100% | 1131.85 | 245 / 245 | 99% | 27.74 | 499 / 502 |
uterus | 100% | 1054.93 | 170 / 170 | 99% | 58.56 | 456 / 459 |
ovary | 100% | 844.33 | 180 / 180 | 99% | 29.17 | 427 / 430 |
thymus | 100% | 1001.42 | 652 / 653 | 99% | 31.10 | 596 / 605 |
kidney | 100% | 852.27 | 89 / 89 | 98% | 26.17 | 880 / 901 |
pancreas | 99% | 705.05 | 324 / 328 | 99% | 44.15 | 176 / 178 |
liver | 100% | 1304.26 | 226 / 226 | 96% | 25.10 | 390 / 406 |
skin | 100% | 1584.65 | 1808 / 1809 | 95% | 37.42 | 450 / 472 |
adrenal gland | 100% | 1383.77 | 258 / 258 | 93% | 25.27 | 215 / 230 |
adipose | 100% | 1407.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 85.09 | 29 / 29 |
spleen | 100% | 2507.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 68.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 80.79 | 1 / 1 |
muscle | 100% | 967.08 | 800 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1096.67 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 802.05 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 1965.75 | 857 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 60% | 9.80 | 48 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042542 | Biological process | response to hydrogen peroxide |
GO_0043029 | Biological process | T cell homeostasis |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0007605 | Biological process | sensory perception of sound |
GO_0032355 | Biological process | response to estradiol |
GO_0061713 | Biological process | anterior neural tube closure |
GO_0043200 | Biological process | response to amino acid |
GO_0021766 | Biological process | hippocampus development |
GO_0034349 | Biological process | glial cell apoptotic process |
GO_0045786 | Biological process | negative regulation of cell cycle |
GO_0010165 | Biological process | response to X-ray |
GO_0009749 | Biological process | response to glucose |
GO_0007507 | Biological process | heart development |
GO_0007611 | Biological process | learning or memory |
GO_0048011 | Biological process | neurotrophin TRK receptor signaling pathway |
GO_0006974 | Biological process | DNA damage response |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0016485 | Biological process | protein processing |
GO_0009411 | Biological process | response to UV |
GO_0001782 | Biological process | B cell homeostasis |
GO_0051146 | Biological process | striated muscle cell differentiation |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0034612 | Biological process | response to tumor necrosis factor |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0007413 | Biological process | axonal fasciculation |
GO_0140639 | Biological process | positive regulation of pyroptotic inflammatory response |
GO_0031647 | Biological process | regulation of protein stability |
GO_0008627 | Biological process | intrinsic apoptotic signaling pathway in response to osmotic stress |
GO_0030218 | Biological process | erythrocyte differentiation |
GO_0030182 | Biological process | neuron differentiation |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0097193 | Biological process | intrinsic apoptotic signaling pathway |
GO_0072734 | Biological process | cellular response to staurosporine |
GO_0071887 | Biological process | leukocyte apoptotic process |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0045165 | Biological process | cell fate commitment |
GO_0046007 | Biological process | negative regulation of activated T cell proliferation |
GO_1902004 | Biological process | positive regulation of amyloid-beta formation |
GO_0001666 | Biological process | response to hypoxia |
GO_0006508 | Biological process | proteolysis |
GO_0035094 | Biological process | response to nicotine |
GO_0001554 | Biological process | luteolysis |
GO_0030163 | Biological process | protein catabolic process |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_1904019 | Biological process | epithelial cell apoptotic process |
GO_0097194 | Biological process | execution phase of apoptosis |
GO_0006915 | Biological process | apoptotic process |
GO_0016241 | Biological process | regulation of macroautophagy |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0032025 | Biological process | response to cobalt ion |
GO_0044346 | Biological process | fibroblast apoptotic process |
GO_0009611 | Biological process | response to wounding |
GO_0030220 | Biological process | platelet formation |
GO_0030889 | Biological process | negative regulation of B cell proliferation |
GO_0051604 | Biological process | protein maturation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0031264 | Cellular component | death-inducing signaling complex |
GO_0005634 | Cellular component | nucleus |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0008233 | Molecular function | peptidase activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0097153 | Molecular function | cysteine-type endopeptidase activity involved in apoptotic process |
GO_0016005 | Molecular function | phospholipase A2 activator activity |
GO_0002020 | Molecular function | protease binding |
GO_0097200 | Molecular function | cysteine-type endopeptidase activity involved in execution phase of apoptosis |
GO_0097199 | Molecular function | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO_0005123 | Molecular function | death receptor binding |
GO_0004190 | Molecular function | aspartic-type endopeptidase activity |
GO_0004861 | Molecular function | cyclin-dependent protein serine/threonine kinase inhibitor activity |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CASP3 |
Protein name | Caspase 3 Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] |
Synonyms | CPP32 |
Description | FUNCTION: Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis . Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins . At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) polymerase PARP1 at a '216-Asp-|-Gly-217' bond . Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain (By similarity). Cleaves and activates caspase-6, -7 and -9 (CASP6, CASP7 and CASP9, respectively) . Cleaves and inactivates interleukin-18 (IL18) . Involved in the cleavage of huntingtin . Triggers cell adhesion in sympathetic neurons through RET cleavage . Cleaves and inhibits serine/threonine-protein kinase AKT1 in response to oxidative stress . Acts as an inhibitor of type I interferon production during virus-induced apoptosis by mediating cleavage of antiviral proteins CGAS, IRF3 and MAVS, thereby preventing cytokine overproduction . Also involved in pyroptosis by mediating cleavage and activation of gasdermin-E (GSDME) . Cleaves XRCC4 and phospholipid scramblase proteins XKR4, XKR8 and XKR9, leading to promote phosphatidylserine exposure on apoptotic cell surface . . |
Accessions | C9JXR7 ENST00000447121.2 P42574 ENST00000393588.8 ENST00000517513.5 ENST00000308394.9 ENST00000523916.5 ENST00000700104.1 A8MVM1 ENST00000700101.1 ENST00000393585.6 A0A8V8TPU5 ENST00000700100.1 |